Prevention of Left Ventricular Dysfunction During Chemotherapy
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The investigators' objective is to assess the efficacy of the combined treatment with
enalapril and carvedilol in the prevention of left ventricular systolic dysfunction in
patients with hematological malignancies submitted to intensive chemotherapy with potential
cardiotoxicity.
The hypothesis is that these drugs administered during chemotherapy may prevent left
ventricular systolic dysfunction.